期刊論文(110.01~110.12)

期刊論文
篇序
作者
姓名(順位)
論文題目
論文性質
期刊名稱/年份/卷期/頁次
屬性
所屬學門領域
所屬學門領域排名
Impact Factor
1
杜漢祥 (3)
Cost-effectiveness evaluation of add-on dapagliflozin for heart failure with reduced ejection fraction from perspective of healthcare systems in Asia-Pacific region.
Original Article
Cardiovasc Diabetol. 2021 Oct 9;20(1):204.
SCI
Endocrinology & Metabolism
10/145
IF
9.951
2
余文良(4,C)
 
Letter
Clin Infect Dis 2021Vol 72/No 5/P 899-900
SCI
Infectious Disease
3/92
IF
9.079
3
杜漢祥 (4)
 
Original Article
Eur J Prev Cardiol. 2021 Apr 23;28(3):326-334.
SCI
Cardiac & cardiovascular System
18/141
IF 7.804
4
沈修年(2,C)
Thyroid Abscess Associated With Pyriform Sinus Fistula
Case Report
Mayo Clinic Proceedings
Vol 96/No 11/P 2854-2855
SCI
Medicine, General & Internal
14/315
IF 7.616
5
杜漢祥 (C)
Cost-Effectiveness Evaluation of Add-on Empagliflozin in Patients With Heart Failure and a Reduced Ejection Fraction From the Healthcare System's Perspective in the Asia-Pacific Region.
Original Article
Front Cardiovasc Med. 2021 Oct 29;8:750381.
SCI
Cardiac & cardiovascular System
30/141
IF
6.05
6
陳欽明(12)
Incidence And Management Of Metabolic Acidosis With Sodium Bicarbonate In The ICU: An International Observational Study
Research Article
Crit Care Vol /No /P25-45
SCI
Critical Care Medicine
 
6 / 36
IF 6.407
7
陳奇祥(5)
陳欽明(7)
余文良(8,C)
The Impacts Of Aspergillosis On Outcome, Burden And Risks For Mortality In Influenza Patients With Critical Illness
Original article
Journal Of Fungi 2021
Vol 7/No 922/P 1-14
SCI
Mycology
4/29
IF 5.816
8
余文良(2,C)
Klebsiella Pneumoniae Harboring Carbapenemase Genes in Taiwan: Its Evolution Over 20 Years, 1998–2019
Review Article
International Journal Of Antimicrobial Agents 2021Vol 58/No 01/P 106354
SCI
Infectious Diseases
17/92
IF 5.283
9
陳奇祥(6)
余文良(7,C)
Epidemiological Correlation Of Pulmonary Aspergillus Infections With Ambient Pollutions And Influenza A (H1N1) In Southern Taiwan
Original Article
J Of Fungi 2021 
Vol 7/No 3/P 227-
SCI
Mycology
4/29
IF 5.816
10
余文良(2,C)
Appropriate Use Of Antimicrobial Therapy For Covid-19 Co-Infection
Letter
Immunotherapy 2021 Sep;13(13):1067-1070.
SCI
Immunology
83/162
IF 4.196
 
11
余文良(2,C)
Covid-19 Associated With Pulmonary Aspergillosis: A Literature Review
Review Article
J Microbiol Immunol 2021 Vol 54/No 1/P 46-53
SCI
Infectious Diseases
28/92
IF
4.399
 
12
陳欽明(2)
陳奇祥(5)
余文良(6,C)
A Mysterious Surge Of Aspergillosis Among Non-Sars-Cov-2 Patients During Covid-19 Pandemic
Letter
J Microbiol Immunol 2021 Vol 54/No 1/P 156-158
SCI
Infectious Diseases
28/92
IF 4.399
13
杜漢祥 (6)
Antimicrobial ability and mechanism analysis of Lactobacillus species against carbapenemase-producing Enterobacteriaceae.
Original Article
J Microbiol Immunol Infect. 2021 Jun;54(3):447-456.
SCI
Infectious Diseases
28/92
IF 4.399
14
余文良 (1)
杜漢祥 (2)
A Double-Edged Sword-Cardiovascular Concerns of Potential Anti-COVID-19 Drugs
Review Article
Cardiovasc Drugs Ther. 2021 Apr;35(2):205-214
SCI
Cardiac & Cardiovascular
61/141
IF 3.727
15
杜漢祥 (3)
Cost-effectiveness analysis of rivaroxaban plus aspirin versus aspirin alone in secondary prevention among patients with chronic cardiovascular diseases.
Original Article
Cardiovasc Drugs Ther. 2021 Jun;35(3):539-547.
SCI
Cardiac & cardiovascular System
61/141
IF 3.727
16
陳志金(4)
Shortening The Time Of The Identification And Antimicrobial Susceptibility Testing On Positive Blood Cultures With MALDI-TOF MS
Original Article
Diagnostics (Basel)
SCI
Medicine, General & Internal
45/167
IF 3.706
 
17
余文良(2,C)
Cefoperazone/Sulbactam: New Composites Against Multiresistant Gram Negative Bacteria?
Review Article
Infect Genet Evol 
2021Vol 88/No /P 1-9
SCI
Infectious Diseases
 
51/92
IF 3.342
 
18
陳欽明(8)
Clinical Efficacy Of Cefoperazone-Sulbactam Versus Piperacillin-Tazobactam In The Treatment Of Hospital-Acquired Pneumonia And Ventilator-Associated Pneumonia
Original Article
Infect Drug Resist Vol 14/No /P 2251-2258
SCI
Infectious Diseases
42 / 93
IF 2.984
19
沈修年(9,C)
Simple Scoring Algorithm To Identify Community-Dwelling Older Adults With Limited Health Literacy: A Cross-Sectional Study In Taiwan
Research Article
BMJ Open
Vol 11/No 11/P E045411
SCI
Medicine, General & Internal
52 / 165
IF 2.692
20
余文良 (1)
杜漢祥 (2)
Cardiovascular Complications Of COVID-19 And Associated Concerns: A Review
Review Article
Acta Cardiol Sin. 2021 Jan;37(1):9-17. 
SCI
Cardiac & Cardiovascular
84/141
IF 2.672
21
陳志金(1)
The Impact Of COVID-19 Control Measures On The Utilization Of Emergency Department During Lunar New Year In Taiwan
Letter
Am J Emerg Med. 2021 May;43:252-254.
SCI
Emergency Medicine
13/32
IF
2.469
22
杜漢祥 (2)余文良(4, C)
Cardiac Involvement Of Covid-19: A Comprehensive Review
Review Article
Am J Med Sci. 2021 Jan;361(1):14-22. 
SCI
Medicine, General & Internal
84/169
IF 2.378
23
杜漢祥 (2)
A Rare Cause of Left Atrium Compression.
Case Report
Int Heart J. 2021 Jul 6.
SCI
Cardiac & cardiovascular System
117/141
IF
1.862
24
余文良(2,C)
Gastrointestinal Tract Bleeding Caused By Cytomegalovirus: A Comprehensive Review
國外教科書
Nova Book: Advances In Health And Disease Vol /No /P 1-44
 
 
 
 
25
余文良(4,C)
Molecular Epidemiology Of Klebsiella Pneumoniae Producing Kpc-17 And Ndm-1 Carbapenemases In Southern Taiwan
國外教科書
Advances In medicine And Biology vol /No /P 185-215
 
 
 
 
26
杜漢祥(1)
第五章、重症病人臨床表現與實驗室檢查
國內指引
新型冠狀病毒感染(COVID-19)重症照護暫行共識第二版
 
 
 
 
27
陳欽明(1)
新冠肺炎的重症危險因子及復健考量的分類建議
國內指引
新型冠狀病毒感染復健治療指引Vol /NO 3/P 6-9
 
 
 
 
28
陳欽明(1,C)
急性高碳酸呼吸衰竭
國內指引
濕化高流量氧氣重症治療台灣專家共識指引Vol /NO 3/P 26-29
 
 
 
 
29
陳欽明(1,C)
一般重症照護—第二版
國內指引
新型冠狀病毒感染(COVID-19)重症照護暫行共識第二版
 
 
 
 
30
陳欽明(1,C)
陳奇祥(2)
維生素D 狀態及其單次巨量補充對台灣成人重症患者的預後指標及死亡之影響:回溯性研究
Original Article
Resuscitation & Intensive Care Med Vol 12/No /P 121-136
 
 
 
 
31
黃惠美(1)
鄭鴻志(2)
陳奇祥(3)
陳欽明(4,C)
智慧化醫療改善呼吸器品質
Original Article
Resuscitation & Intensive Care Med Vol 6/No /P 53-62
 
 
 
 
列印